Initiation of noninvasive ventilation in patients with amyotrophic lateral sclerosis
- PMID: 39243146
- DOI: 10.1002/mus.28250
Initiation of noninvasive ventilation in patients with amyotrophic lateral sclerosis
Abstract
Introduction/aims: Noninvasive ventilation (NIV) has been shown to improve survival and symptom burden in patients with amyotrophic lateral sclerosis (ALS). However, limited data exist regarding the clinical and physiological parameters at the time of NIV initiation. This study aimed to describe the clinical characteristics and respiratory physiological markers in a cohort of ALS patients with chronic respiratory failure.
Methods: This is a single-center retrospective cohort study of patients with ALS assessed for NIV initiation between February 2012 and January 2021. NIV was initiated based on insurance eligibility criteria: daytime hypercapnia, defined by partial pressure of carbon dioxide (PaCO2) >45 mm Hg using diurnal transcutaneous CO2 (TcCO2) as a surrogate, a maximal inspiratory pressure (MIP) <60 cmH2O or forced vital capacity (FVC) <50% predicted normal.
Results: We identified 335 patients with ALS and chronic respiratory failure referred to an outpatient home ventilation clinic for NIV initiation. The mean age was 64 years ±11; 151 (45%) were female, 326 (97%) were white, and 100 (29%) had bulbar-onset ALS. At the time of NIV initiation, the mean FVC was 64% ± 19%, the mean MIP; 41 cmH2O ± 17, and diurnal TcCO2; 40 ± 6 mmHg. The most common reasons for NIV initiation were MIP <60 cmH2O (58%) and multiple concomitant indications (28%). Within 1 year of NIV initiation, 126 (37%) patients were deceased.
Discussion: We found that impairment in inspiratory force was the most common reason for NIV initiation and often preceded significant declines in FVC.
Keywords: amyotrophic lateral sclerosis; home mechanical ventilation; neuromuscular disease; noninvasive ventilation; respiratory failure.
© 2024 The Author(s). Muscle & Nerve published by Wiley Periodicals LLC.
References
REFERENCES
-
- Niedermeyer S, Murn M, Choi PJ. Respiratory failure in amyotrophic lateral sclerosis. Chest. 2019;155(2):401‐408.
-
- Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non‐invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol. 2006;5(2):140‐147.
-
- Jacobs TL, Brown DL, Baek J, Migda EM, Funckes T, Gruis KL. Trial of early noninvasive ventilation for ALS: a pilot placebo‐controlled study. Neurology. 2016;87(18):1878‐1883.
-
- Sarasate M, González N, Córdoba‐Izquierdo A, et al. Impact of early non‐invasive ventilation in amyotrophic lateral sclerosis: a multicenter randomized controlled trial. J Neuromuscul Dis. 2023;10(4):627‐637.
-
- Ackrivo J, Hsu JY, Hansen‐Flaschen J, Elman L, Kawut SM. Noninvasive ventilation use is associated with better survival in amyotrophic lateral sclerosis. Ann Am Thorac Soc. 2021;18(3):486‐494.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
